Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis

Journal of Anxiety Disorders

Volumn 26, Issue 1, 2012, Pages 1-11

  Gonçalves, Daniela C ^a   Byrne, Gerard J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Generalized anxiety disorder; Intervention; Older adults; Treatment

Indexed keywords

ALPIDEM; ALPRAZOLAM; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; HYPNOTIC SEDATIVE AGENT; KETAZOLAM; NORTRIPTYLINE; OXAZEPAM; PIPERAZINE DERIVATIVE; PLACEBO; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

COGNITIVE THERAPY; DRUG EFFICACY; DRUG RESPONSE; GENERALIZED ANXIETY DISORDER; HUMAN; INVOLUNTARY COMMITMENT; META ANALYSIS; PSYCHOTHERAPY; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; HUMANS; MIDDLE AGED; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 84855476969     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2011.08.010     Document Type: Review

References (81)

1. Arean P.A., Alvidrez J., Barrera A., Robinson G.S., Hicks S. Would older medical patients use psychological services?. Gerontologist 2002, 42(3):392-398.
2. Beaudreau S.A., O'Hara R. Late-life anxiety and cognitive impairment: a review. American Journal of Geriatric Psychiatry 2008, 16(10):790-803.
3. Beaudreau S.A., O'Hara R. The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. Psychology and Aging 2009, 24(2):507-512.
4. Beekman A.T.F., Bremmer M.A., Deeg D.J.H., van Balkom A.J.L.M., Snut J.H., de Beurs E., et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. International Journal of Geriatric Psychiatry 1998, 13(10):717-726.
5. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
6. Brenes G.A., Guralnik J.M., Williamson J.D., Fried L.P., Simpson C., Simonsick E.M., et al. The influence of anxiety on the progression of disability. Journal of the American Geriatrics Society 2005, 53(1):34-39.
7. Brenes G.A., Knudson M., McCall W.V., Williamson J.D., Miller M.E., Stanley M.A. Age and racial differences in the presentation and treatment of generalized anxiety disorder in primary care. Journal of Anxiety Disorders 2008, 22(7):1128-1136.
8. Brenes G.A., Miller M.E., Stanley M.A., Williamson J.D., Knudson M., McCall W.V. Insomnia in older adults with generalized anxiety disorder. American Journal of Geriatric Psychiatry 2009, 17(6):465-472.
9. Bresolin N., Monza G., Scarpini E., Scarlato G., Straneo G., Martinazzoli A., et al. Treatment of anxiety with ketazolam in elderly patients. Clinical Therapeutics 1988, (5):536-542.
10. Bryant C., Jackson H., Ames D. The prevalence of anxiety in older adults: methodological issues and a review of the literature. Journal of Affective Disorders 2008, 109(3):233-250.
11. Byers A.L., Yaffe K., Covinsky K.E., Friedman M.B., Bruce M.L. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Archives of General Psychiatry 2010, 67(5):489-496.
12. Byrne G.J., Pachana N.A. Anxiety and depression in the elderly: do we know any more?. Current Opinion in Psychiatry 2010, 23(6):504-509.
13. Cohn J.B. Double-blind safety and efficacy comparison of alprazolam and placebo in the treatment of anxiety in geriatric-patients. Current Therapeutic Research: Clinical and Experimental 1984, 35(1):100-112.
14. Davidson J., Allgulander C., Pollack M.H., Hartford J., Erickson J.S., Russell J.M., et al. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Human Psychopharmacology: Clinical and Experimental 2008, 23(6):519-526.
15. De Beurs E., Beekman A.T.F., van Balkom A.J.L.M., Deeg D.J.H., van Dyck R., van Tilburg W. Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychological Medicine 1999, 29(3):583-593.
16. Deeks J.J., Altman D.G., Bradburn M.J. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic reviews in health care: meta-analysis in context 2001, 285-312. British Medical Association, London. M. Egger, G.D. Smith, D.G. Altman (Eds.).
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7(3):177-188.
18. Di Costanzo E., Rovea A. La profilassi della sindrome di astinenza da benzodiazepine nell'anziano: l'eficacia della carbamazepina. Uno studio in doppio cieco con placebo. Minerva Psichiatrica 1992, 33(4):301-304.
19. Doucet J., Chassagne P., Trivalle C., Landrin I., Pauty M.D., Kadri N., et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. Journal of the American Geriatrics Society 1996, 44(8):944-948.
20. Dugas M.J., Anderson K.G., Deschenes S.S., Donegan E. Generalized anxiety disorder publications: where do we stand a decade later?. Journal of Anxiety Disorders 2010, 24(7):780-784.
21. Enkelmann R. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology 1991, 105(3):428-432.
22. Eriksson H., Mezhebovsky I., Magi K., She F., Datto C. Double-blind, randomised study of extended release quetiapine fumarate (Quetiapine XR) monotherapy in elderly patients with generalized anxiety disorder (GAD). International Journal of Psychiatry in Clinical Practice 2008, 12(4):332-333.
23. Fletcher J. What is heterogeneity and is it important?. British Medical Journal 2007, 334(7584):94-96.
24. Frattola L., Piolti R., Bassi S., Albizzati M.G., Cesana B.M., Bottani M.S., et al. Effects of alpidem in anxious elderly outpatients: a double-blind, placebo controlled trial. Clinical Neuropharmacology 1992, 15(6):477-487.
25. Gelenberg A.J., Lydiard R.B., Rudolph R.L., Aguiar L., Haskins J.T., Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder - a 6-month randomized controlled trial. JAMA: Journal of the American Medical Association 2000, 283(23):3082-3088.
26. Gonçalves D.C., Pachana N.A., Byrne G.J. Prevalence and correlates of generalized anxiety disorder among older adults in the Australian National Survey of Mental Health and Well-Being. Journal of Affective Disorders 2011, 132(1-2):223-230.
27. Gorenstein E.E., Papp L.A. Cognitive-behavioral therapy for anxiety in the elderly. Current Psychiatry Reports 2007, 9(1):20-25.
28. Gorenstein E.E., Kleber M.S., Moblman J., DeJesus M., Gorman J.M., Papp L.A. Cognitive-behavioral therapy for management of anxiety and medication taper in older adults. American Journal of Geriatric Psychiatry 2005, 13(10):901-909.
29. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Ruan W.J., Goldstein R.B., et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine 2005, 35(12):1747-1759.
30. Hendriks G.J., Voshaar R.C.O., Keijsers G.P.J., Hoogduin C.A.L., van Balkom A. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatrica Scandinavica 2008, 117(6):403-411.
31. Hollis S., Campbell F. What is meant by intention to treat analysis? Survey of published controlled trials. British Medical Journal 1999, 319(7211):670-674.
32. Huedo-Medina, T., Sanchez-Meca, J., Marin-Martinez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Center for Health, Intervention, and Prevention, 19. Available from: http://digitalcommons.uconn.edu/chip_docs/19.
33. Hunot V., Churchill R., de Lima M.S., Teixeira V. Psychological therapies for generalised anxiety disorder. Cochrane Database of Systematic Reviews 2007, (1):CD001848.
34. Hunt C., Issakidis C., Andrews G. DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 2002, 32(4):649-659.
35. Katz I.R., Reynolds C.F., Alexopoulos G.S., Hackett D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. Journal of the American Geriatrics Society 2002, 50(1):18-25.
36. Kimura M., Tateno A., Robinson R.G. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. American Journal of Geriatric Psychiatry 2003, (3):320-327.
37. Koepke H.H., Gold R.L., Linden M.E., Lion J.R., Rickels K. Multi-center controlled study of oxazepam in anxious elderly outpatients. Psychosomatics 1982, 23(6):641-645.
38. Lau J., Ioannidis J.P.A., Schmid C.H. Quantitative synthesis in systematic reviews. Annals of Internal Medicine 1997, 127(9):820-826.
39. Lau J., Ioannidis J.P.A., Terrin N., Schmid C.H., Olkin I. Evidence based medicine: the case of the misleading funnel plot. British Medical Journal 2006, 333(7568):597-600.
40. Lecrubier Y., Puech A.J., Azcona A., Bailey P.E., Lataste X. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology 1993, 112(1):129-133.
41. Lenze E.J., Mulsant B.H., Mohlman J., Shear M.K., Dew M.A., Schulz R., et al. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. American Journal of Geriatric Psychiatry 2005, 13(1):77-80.
42. Lenze E.J., Mulsant B.H., Shear M.K., Dew M.A., Miller M.D., Pollock B.G., et al. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. American Journal of Psychiatry 2005, 162(1):146-150.
43. Lenze E.J., Rollman B.L., Shear M.K., Dew M.A., Pollock B.G., Ciliberti C., et al. Escitalopram for older adults with generalized anxiety disorder a randomized controlled trial. JAMA: Journal of the American Medical Association 2009, 301(3):295-303.
44. Mackenzie C.S., Scott T., Mather A., Sareen J. Older adults' help-seeking attitudes and treatment beliefs concerning mental health problems. American Journal of Geriatric Psychiatry 2008, 16(12):1010-1019.
45. Majercsik E., Haller J. Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004, 28(7):1161-1169.
46. Mantella R.C., Butters M.A., Dew M.A., Mulsant B.H., Begley A.E., Tracey B., et al. Cognitive impairment in late-life generalized anxiety disorder. American Journal of Geriatric Psychiatry 2007, 15(8):673-679.
47. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., et al. The functional neuroanatomy of the placebo effect. American Journal of Psychiatry 2002, 159(5):728-737.
48. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Lancet 1999, 354(9193):1896-1900.
49. Mohlman J. More power to the executive? A preliminary test of CBT plus executive skills training for treatment of late-life GAD. Cognitive and Behavioral Practice 2008, 15(3):306-316.
50. Mohlman, J. A community based survey of older adults' preferences for treatment of anxiety. Psychology and Aging, , in press. doi:10.1037/a0023126.
51. Mohlman J., Gorman J.M. The role of executive functioning in CBT: a pilot study with anxious older adults. Behaviour Research and Therapy 2005, 43(4):447-465.
52. Mohlman J., Gorenstein E.E., Kleber M., de Jesus M., Gorman J.M., Papp L.A. Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder - two pilot investigations. American Journal of Geriatric Psychiatry 2003, 11(1):24-32.
53. Mokhber N., Azarpazhooh M.R., Khajehdaluee M., Velayati A., Hopwood M. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. Psychiatry and Clinical Neurosciences 2010, (2):128-133.
54. Moncrieff J., Chruchill R., Drummond D.C., Mcguire H. Development of a quality assessment instrument for trials of treatments of depression and neurosis. International Journal of Methods in Psychiatric Research 2001, 10(3):126-133.
55. Montgomery S., Chatamra K., Pauer L., Whalen E., Baldinetti F. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. British Journal of Psychiatry 2008, 193(5):389-394.
56. Nordhus I., Pallesen S. Psychological treatment of late-life anxiety: an empirical review. Journal of Consulting and Clinical Psychology 2003, 71(4):643-651.
57. Ostir G.V., Goodwin J.S. High anxiety is associated with an increased risk of death in an older tri-ethnic population. Journal of Clinical Epidemiology 2006, 59(5):534-540.
58. Pachana N.A., Byrne G.J., Siddle H., Koloski N., Harley E., Arnold E. Development and validation of the geriatric anxiety inventory. International Psychogeriatrics 2007, 19(1):103-114.
59. Pinquart M., Duberstein P.R. Treatment of anxiety disorders in older adults: a meta-analytic comparison behavioral and pharmacological interventions. American Journal of Geriatric Psychiatry 2007, 15(8):639-651.
60. Rickels K., Schweizer E., DeMartinis N., Mandos L., Mercer C. Gepirone and diazepam in generalized anxiety disorder: A placebo-controlled trial. Journal of Clinical Psychopharmacology 1997, 17(4):272-277.
61. Ried L.D., Johnson R.E., Gettman D.A. Benzodiazepine exposure and functional status in older people. Journal of the American Geriatrics Society 1998, 46(1):71-76.
62. Schoevers R.A., Deeg D.J.H., van Tilburg W., Beekman A.T.F. Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients. American Journal of Geriatric Psychiatry 2005, 13(1):31-39.
63. Schuurmans J., Comijs H., Emmelkamp P.M.G., Gundy C.M.M., Weijnen I., Van Den Hout M., et al. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults. American Journal of Geriatric Psychiatry 2006, 14(3):255-263.
64. Secoli S.R., Figueras A., Lebrao M.L., de Lima F.D., Santos J.L.F. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs & Aging 2010, 27(9):759-770.
65. Segal D.L., June A., Payne M., Coolidge F.L., Yochim B. Development and initial validation of a self-report assessment tool for anxiety among older adults: The Geriatric Anxiety Scale. Journal of Anxiety Disorders 2010, 24(7):709-714.
66. Sirey J.A., Bruce M.L., Alexopoulos G.S., Perlick D.B., Friedman S.J., Meyers B.S. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. American Journal of Psychiatry 2001, 158(3):479-481.
67. Stanley M.A., Beck J.G., Glassco J.D. Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches. Behavior Therapy 1996, 27(4):565-581.
68. Stanley M.A., Roberts R.E., Bourland S.L., Novy D.M. Anxiety disorders among older primary care patients. Journal of Clinical Geropsychology 2001, 7(2):105-116.
69. Stanley M.A., Beck J.G., Novy D.M., Averill P.M., Swann A.C., Diefenbach G.J., et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting and Clinical Psychology 2003, 71(2):309-319.
70. Stanley M.A., Hopko D.R., Diefenbach G.J., Bourland S.L., Rodriguez H., Wagener P. Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care - preliminary findings. American Journal of Geriatric Psychiatry 2003, 11(1):92-96.
71. Stanley M.A., Wilson N.L., Novy D.M., Rhoades H.M., Wagener P.D., Greisinger A.J., et al. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA: Journal of the American Medical Association 2009, 301(14):1460-1467.
72. StataCorp Statistical software: release 11.0 2009, Stata Corporation, College Station, TX.
73. Sterne J.A.C., Bradburn M.J., Egger M. Meta-analysis in stata. Systematic reviews in health care: meta-analysis in context 2001, 347-369. British Medical Association, London. M. Egger, G.D. Smith, D.G. Altman (Eds.).
74. Thorp S.R., Ayers C.R., Nuevo R., Stoddard J.A., Sorrell J.T., Wetherell J.L. Meta-analysis comparing different behavioral treatments for late-life anxiety. American Journal of Geriatric Psychiatry 2009, 17(2):105-115.
75. Trollor J.N., Anderson T.M., Sachdev P.S., Brodaty H., Andrews G. Prevalence of mental disorders in the elderly: The Australian National Mental Health and Well-being Survey. American Journal of Geriatric Psychiatry 2007, 15(6):455-466.
76. Wetherell J.L., Gatz M., Craske M.G. Treatment of generalized anxiety disorder in older adults. Journal of Consulting and Clinical Psychology 2003, 71(1):31-40.
77. Wetherell J.L., Lenze E.J., Stanley M.A. Evidence-based treatment of geriatric anxiety disorders. Psychiatric Clinics of North America 2005, 28(4):871-896.
78. Wetherell J.L., Maser J.D., van Balkom A. Anxiety disorders in the elderly: outdated beliefs and a research agenda. Acta Psychiatrica Scandinavica 2005, 111(6):401-402.
79. Wetherell J.L., Ayers C.R., Sorrell J.T., Thorp S.R., Nuevo R., Belding W., et al. Modular psychotherapy for anxiety in older primary care patients. American Journal of Geriatric Psychiatry 2009, 17(6):483-492.
80. Wetherell J.L., Liu L., Patterson T.L., Afari N., Ayers C.R., Thorp S.R., et al. Acceptance and commitment therapy for generalized anxiety disorder in older adults: a preliminary report. Behavior Therapy 2011, 42(1):127-134.
81. Wetherell J.L., Stoddard J.A., White K.S., Kornblith S., Nguyen H., Andreescu C., et al. Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study. International Journal of Geriatric Psychiatry 2011, 26(8):869-875.